NASDAQ:SMTI
Sanara MedTech Inc.
Sanara MedTech Inc.'s revenue grew 19.0% in fiscal 2025 to $103.1M while operating margin rose to 7.1%, its highest in 10 years. Free cash flow was $2.2M, 2.1% of revenue, and the diluted share count rose 1.6%.Summary generated from Sanara MedTech Inc.'s SEC filings. Latest annual report filed Mar 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$103.1M
Revenue growth+19.0%
Revenue, 5-yr CAGR+45.9%
Gross margin92.7%
Operating margin7.1%
Net margin−36.4%
ROIC12.9%
Return on equity−165.7%
Debt / equity7.74
Free cash flow$2.2M
FCF margin2.1%
Share count change+1.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 24 | 46 | 65 | 87 | 103 |
| Operating income | −7 | −13 | −4 | 1 | 7 |
| Net income | −8 | −8 | −4 | −10 | −38 |
| Free cash flow | −5 | −6 | −4 | −0 | 2 |
Recent filings
- 8-KResults of a shareholder vote
Oct 1, 2026 - 4Insider transaction report
Sep 16, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 8-K/AAmended entry into a material agreement
Aug 11, 2026 - 8-KEntry into a material agreement
Jul 29, 2026 - 8-KResults of a shareholder vote
Jun 9, 2026 - 4Insider transaction report
Jun 5, 2026